NUVIGIL

This brand name is authorized in Australia, Brazil, Israel, Turkey, United States

Active ingredients

The drug NUVIGIL contains one active pharmaceutical ingredient (API):

1 Armodafinil UNII V63XWA605I - ARMODAFINIL

Armodafinil is an indirect dopamine receptor agonist; both armodafinil and modafinil bind in vitro to the dopamine transporter and inhibit dopamine reuptake. Armodafinil (R-modafinil) has pharmacological properties similar to those of modafinil (a mixture of R- and S-modafinil), to the extent tested in animal and in vitro studies. Read about Armodafinil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NUVIGIL Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA13		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10912H, 10919Q, 10922W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 537521030009807, 537521030009907
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7833, 7880
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699638014026, 8699638014033, 8699638014132
Country: US	FDA, National Drug Code	Identifier(s): 63459-205, 63459-215, 63459-220, 63459-225